EMILY MILLER: Open Payments
NPI 1053862789 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 30 payments from 16 companies in 2025. Trend: 2023 $19 · 2024 $214 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $178 |
| E.R. Squibb & Sons, L.L.C. | 3 | $151 |
| BIOTRONIK INC. | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $56 |
| SCPHARMACEUTICALS INC. | 2 | $50 |
| Amgen Inc. | 3 | $48 |
| Philips North America LLC | 2 | $45 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $34 |
Products named: WINREVAIR, CAMZYOS, AMVIA EDGE, LEQVIO, JARDIANCE, Wegovy, FUROSCIX, REPATHA.
Industry payments across SC — which companies pay providers there.
